Trial Profile
A Pilot Study of Vitamin D Deficiency and Myalgias, Arthralgias and/or Joint Stiffness associated with Letrozole (Femara).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 02 Feb 2012 Inclusion and exclusion criteria amended from NCT.
- 10 Aug 2011 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 10 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.